Greater China
-
Asia’s bond market set a blistering pace this week, with nearly $4.2bn of deals sold through Wednesday and one of the busiest days since the global spread of the coronavirus. But although the successful deals are a sign that market sentiment is improving, bankers are cautious about what is yet to come. Morgan Davis reports. -
Hansoh Pharmaceutical Group, a China-based drug maker, pocketed HK$3.49bn ($450m) from a larger-than-planned issue of primary shares this week.
-
How can banks conduct due diligence at a time when so few are willing or able to travel? Staff at one Chinese broker have been presented with a rather unappealing solution.
-
Do investors matter in China’s bond market? Not much, judging by a recent series of bondholder meetings. HNA Group Co and Gemdale are the latest companies to push their luck. It is time for regulators to push back.
-
UBS has hired Fan Yang from China Merchants Securities International as chairman of global banking for Asia, a newly created position at the Swiss firm.
-
China’s Dr Peng Telecom & Media Group Co is looking to extend the maturity date of a bond coming due in June.
-
Shenzhen Zhaoheng Hydropower Group has obtained a maturity extension for a $128m loan sealed in 2017, after difficult market conditions put pressure on its refinancing abilities.
-
Hansoh Pharmaceutical Group, a China-based drug maker, has pocketed HK$3.49bn ($450m) from a larger-than-planned issue of primary shares.
-
Chinese local governments will receive another Rmb1tr ($141.4bn) in quota to issue special purpose bonds, as the authorities look to boost infrastructure spending and support economic growth.
-
Recent dollar bonds in Asia offer timely insight into the ingredients needed to seal deals in the Covid-19 environment.
-
Pressure on Asia’s loan market has eased recently as funding costs come under control and the Covid-19 spread in China slows down. But bankers hoping for a quick rebound in deal flow should keep their expectations in check.
-
Sino Biopharmaceutical’s shares tumbled about 8% on Tuesday after its chief executive officer, Tse Ping, sold a portion of his stake in the company for HK$2.27bn ($292.9m).
